Exhibit 99.1
Annual General Meeting Biofrontera Aktiengesellschaft December 14, 2021, 11:00 AM |
Voting results:
Agenda Items | Number of Shares with Valid Votes | % of Registered Share Capital | Votes for | % Votes For | Votes Against | % Votes Against | Proposed Decision | |||||||||||||||||||
2 Resolution concerning the discharge of the members of the Management Board for the 2020 financial year | 35,567,873 | 62.71 | 16,997,765 | 47.7897 | 18,570,108 | 52.2103 | rejected | |||||||||||||||||||
3 Resolution concerning the discharge of the members of the Supervisory Board for the 2020 financial year | 35,206,044 | 62.07 | 16,654,145 | 47.3048 | 18,551,899 | 52.6952 | rejected | |||||||||||||||||||
4 Resolution concerning the appointment of the auditors of the separate and consolidated financial statements for the 2021financial year and as auditor for a possible audit review of the condensed interim financial statements and interim management report | 35,864,573 | 63.23 | 35,067,791 | 97.7783 | 796,782 | 2.2217 | approved | |||||||||||||||||||
5a Elections to the Supervisory Board, Dr. Heikki Lanckriet, CEO of 4basebio PLC, Cambridge, UK, resident of Cambridge, UK | 36,020,251 | 63.51 | 32,840,700 | 91.1728 | 3,179,551 | 8.8272 | approved | |||||||||||||||||||
5b Elections to the Supervisory Board, Dr. Helge Lubenow, CEO of Proteomedix AG, Zurich, Switzerland, resident of Bad Nauheim, Germany | 35,318,964 | 62.27 | 33,125,716 | 93.7901 | 2,193,248 | 6.2099 | approved | |||||||||||||||||||
5c Elections to the Supervisory Board, Prof. Dr. Franca Ruhwedel, Professor of Finance and Accounting at the Rhine-Waal University of Applied Sciences, Kamp-Lintfort, resident of Duisburg | 36.021.004 | 63.51 | 35.074.176 | 97.3714 | 946.828 | 2.6286 | approved |
1 |
Annual General Meeting Biofrontera Aktiengesellschaft December 14, 2021, 11:00 AM |
Agenda Items | Number of Shares with Valid Votes | % of Registered Share Capital | Votes for | % Votes For | Votes Against | % Votes Against | Proposed Decision | |||||||||||||||||||
5d Elections to the Supervisory Board, Mr. Karlheinz Schmelig, Managing Director, Creathor Venture Management GmbH, Bad Homburg, resident of Bensheim | 35,069,375 | 61.83 | 33,830,890 | 96.4684 | 1,238,485 | 3.5316 | approved | |||||||||||||||||||
5e Elections to the Supervisory Board, Dr. Jörgen Tielmann, Attorney at Law/Partner at Luther Rechtsanwaltsgesellschaft mbH, Cologne, resident of Hamburg | 35,076,792 | 61.84 | 34,585,948 | 98.6006 | 490,844 | 1.3994 | approved | |||||||||||||||||||
5d Elections to the Supervisory Board, Mr. Wilhelm K. T. Zours, Member of the Management Board of DELPHI Unternehmensberatung AG, Heidelberg, resident of Heidelberg | 36,091,859 | 63.63 | 32,609,794 | 90.3522 | 3,482,065 | 9.6478 | approved | |||||||||||||||||||
6 Resolution on the confirmation of remuneration of the Supervisory Board | 34,786,334 | 61.33 | 33,493,965 | 96.2848 | 1,292,369 | 3.7152 | approved | |||||||||||||||||||
7 Resolution on the approval of the remuneration of the members of the Board of Management | 34,743,765 | 61.26 | 33,499,225 | 96.4179 | 1,244,540 | 3.5821 | approved | |||||||||||||||||||
8 Resolution on the authorization to create new Authorized Capital 2021 and on the corresponding amendments to the amendments to the Articles of Association | 35,024,789 | 61.75 | 18,426,480 | 52.6098 | 16,598,309 | 47.3902 | rejected | |||||||||||||||||||
9 Resolution on (a) the authorization to issue profit-sharing certificates, warrants and convertible bonds as well as warrants and convertible bonds with the possibility of excluding subscription rights, (b) the creation of a new conditional capital Conditional Capital II and (c) on the amendment of § 7 (5) of the Articles of Association (share capital) | 35,006,131 | 61.72 | 18,108,711 | 51.7301 | 16,897,420 | 48.2699 | rejected |
Contact details: Biofrontera AG, Hemmelrather Weg 201, D-51377 Leverkusen, Anke zur Mühlen, Phone: +49 (0) 214 87632 22, www.biofrontera.com
2 |